Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-04-03

Clinical Trial Update: Hybrid Type 2 Implementation-Effectiveness Trial of a Third Wave Virtual Reality Treatment for Youth Depression/Anxiety [Phase 2]

View source ↗

Summary

ClinicalTrials.gov update for a Phase 2 implementation-effectiveness trial of a third-wave virtual reality treatment targeting youth depression and anxiety, sta…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Orygen | Conditions: Depression Anxiety Disorder | Phase 2 | Status: NOT_YET_RECRUITING